Colorectal cancer epidemiology
Colorectal cancer CRC is the third most common neoplasm, and its prevalence increases with age and with social and economic status urbanization. Studies have shown an increased risk of cancer in DM patients, especially along the digestive tract, including CRC, without being able to find a clear pathogenic link between the two chronic diseases.
In this review we intend to analyze the relationship between DM and CRC in terms of epidemiology and risk factors. DM particularly type 2 diabetes mellitus -T2DM, which is preponderant and CRC share certain risk factors that have as central element the energy metabolism imbalance due to an unhealthy lifestyle e.
Biopsy and FNAC are invasive procedures, especially in the case of deeply located tumors, and may present severe complications such as infection, bleeding, or inflammation. More importantly, they also carry the risk of seeding tumor cells around the sampling area. Indeed, detached cells can be cleared by interstitial fluids to lymph nodes, or into the veins draining the tissue, thus entering the circulation.
We evaluated, separately, the incidence and mortality rates worldwide and mortality rates in Romania for CRC during the last 25 years. For DM we evaluated its prevalence worldwide during the last 20 years.
Colorectal cancer epidemiology incidence mortality survival and risk factors
However, users may print, download, or email articles for individual use. This abstract may be abridged.
No warranty is given about the accuracy colorectal cancer epidemiology the copy. Users should refer to the original published version of the material for the full abstract.
Colorectal Cancer Screening
Important User Information: Remote access to EBSCO's databases is permitted to patrons of subscribing institutions accessing from remote locations for personal, non-commercial use.
However, remote access to EBSCO's databases from non-subscribing institutions is not allowed if the purpose of the use is for commercial gain through cost reduction colorectal cancer epidemiology avoidance for a non-subscribing institution.
